Allstate Corporation’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-15,151
Closed -$551K 695
2021
Q2
$551K Buy
15,151
+321
+2% +$13.3K 0.02% 497
2021
Q1
$649K Buy
14,830
+2,543
+21% +$119K 0.02% 458
2020
Q4
$564K Buy
12,287
+426
+4% +$17.7K 0.02% 468
2020
Q3
$394K Buy
11,861
+12
+0.1% +$383 0.01% 492
2020
Q2
$348K Buy
11,849
+3,843
+48% +$111K 0.01% 543
2020
Q1
$216K Buy
+8,006
New +$239K 0.01% 578

Other funds holding AVNS

Allstate Corporation's AVNS Position: Q3 2021 in Review

Allstate Corporation sold out of Avanos Medical (AVNS) in Q3 2021, closing a stake of 15,151 shares — an estimated $551K sold.

Allstate Corporation first reported a position in AVNS in Q1 2020 and held it in 6 quarters. The position peaked at $649K in Q1 2021. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2021.

  • Allstate Corporation reported no remaining Avanos Medical position as of Q3 2021 after selling out during the quarter.
  • Allstate Corporation sold 15,151 Avanos Medical shares in Q3 2021, an estimated $551K.
  • Allstate Corporation first reported a position in Avanos Medical in Q1 2020 and held it in 6 quarters.
  • Allstate Corporation's Avanos Medical position peaked at $649K in Q1 2021.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2021.

Based on Allstate Corporation's 13F filing for Q3 2021, filed 15 Nov 2021.